AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Recursion Pharmaceuticals vs Freed AI

Recursion Pharmaceuticals

Recursion Pharmaceuticals

VS
Freed AI

Freed AI

Verdict by Category

Detailed category analysis is not available for this comparison.
View Recursion Pharmaceuticals View Freed AI

Detailed Comparison

Feature
Recursion Pharmaceuticals
Freed AI
Pricing
CustomRecursion operates through three revenue streams: pharma collaboration agreements, data licensing, and its own internal drug pipeline. Pharma partnerships (Roche/Genentech, Sanofi) are structured as multi-year agreements with upfront payments and milestone-based payments tied to program progress. Recursion has earned $500M+ in cumulative milestones to date, with $134M from Sanofi alone. Data licensing allows external researchers and pharma companies to access Recursion's proprietary biology maps and phenomics datasets for their own target discovery programs. Recursion's own clinical programs (REC-4881, REC-1245, REC-4539) will generate revenue through future partnering, co-development, or commercialization deals as they advance through clinical trials. Total 2025 revenue: $74.7M. Contact Recursion through recursion.com for partnership inquiries.
PaidFreed publishes clear, tiered pricing, unlike some enterprise-focused competitors that require a sales call. The AI Scribe has four tiers: Starter at $39/month (billed annually) or $59/month (billed monthly) for 1 clinician and up to 40 notes/month; Core at roughly $59-79/month for unlimited notes and Clinical Evidence; Premier at $104/month (annual) or $119/month (monthly) for the full suite including EHR push, dictation, and ICD-10/CPT coding; and custom Groups pricing for multi-clinician clinics with admin dashboards, SSO, and volume discounts. Freed Front Desk, the separate AI receptionist product, starts at $149/month per block of 250 calls. All AI Scribe plans include a 7-day free trial with no credit card required, and residents, students, and trainees can get the Core plan free through Freed's pilot program.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Chatbots
Summary
AI-native drug discovery OS with industrial-scale automated labs and $500M+ in pharma partnerships
Affordable AI medical scribe and front desk for independent clinics, starting at $39/month
Recursion Pharmaceuticals

Recursion Pharmaceuticals Pros & Cons

Pros

  • $500M+ in pharma partnership milestones — most validated AI drug platform by commercial revenue
  • Recursion OS is the most vertically integrated AI drug discovery system — biology to clinic in one platform
  • Industrial-scale automated labs generate data no other company can replicate
  • Phase 2 FAP clinical proof of concept — 53% polyp reduction — FDA registration discussions began
  • Roche/Genentech and Sanofi as partners — two of the world's top 5 pharma companies
  • Exscientia acquisition in 2024 added cutting-edge small molecule AI design capabilities
  • Cash runway guided into early 2028 — disciplined capital allocation

Cons

  • Stock (RXRX) is below $5 — significant market skepticism on timeline to commercial drugs
  • Operating cash burn of ~$390M in 2026 — needs continued capital or milestone payments
  • Acquired Exscientia in 2024 — integration complexity and added operational overhead
  • No approved drugs yet — clinical proof of concept still early stage
  • Proprietary platform requires industrial-scale automation infrastructure that can't be self-built
Freed AI

Freed AI Pros & Cons

Pros

  • Transparent, published pricing starting at $39/month, unusually clear for the AI medical scribe category
  • Purpose-built for independent and small-to-midsized clinics rather than enterprise health systems
  • Combines scribing, cited clinical Q&A, and coding suggestions in one affordable tool
  • High reported accuracy (98% recall on medical terms) and accessible US-based human support
  • New Front Desk product extends the same AI to patient calls and messaging, not just documentation
  • 7-day free trial with no credit card required, plus free access for residents and students

Cons

  • No native EHR API write-back for most systems; EHR push works only with browser-based EHRs, not deep two-way integrations like Epic or Oracle Health
  • Front Desk is still in beta with a waitlisted 'Advanced' tier, so scheduling and insurance verification aren't yet automated
  • Higher tiers (Premier, Groups) are needed to unlock EHR push, coding, and multi-user features, which adds up for growing clinics
  • Built for browser-based, ambulatory workflows, so it's a weaker fit for large hospital systems already standardized on Epic or Cerner
  • Audio is only temporarily retained during processing, so there's no persistent recording to fall back on after a note is finalized